baricitinib
Gohibic™ (vilobelimab): A Treatment Option For Critically Ill COVID-19 Patients
This article describes the standard of care for hospitalized patients with COVID-19 in need of supplemental oxygen ...
SEPTEMBER 23, 2024
FDA Warns of Serious Risks, Including Death, With Tofacitinib
The FDA is requiring the addition of warnings about increased risks for cancer, serious cardiovascular events and ...
SEPTEMBER 2, 2021
FDA Authorizes Baricitinib Alone as COVID-19 Treatment
The FDA revised the emergency use authorization (EUA) for baricitinib to enable its use alone for the treatment of ...
JULY 29, 2021
Load more